ABOUT US
BioMedha is a UK-based, pre-clinical contract research organisation providing bioscience expertise to global drug discovery clients based at BioCity in Nottingham. We are industry-experienced, In vitro biology-focused scientists and can add significant value to our clients’ drug discovery programmes by undertaking key elements of the early-stage drug discovery process.
Supporting clients across pharma, biotech, virtual companies, as well as spin outs and academia, our passionate team of scientists brings substantial pre-clinical drug discovery biology experience.
Bespoke services include:
Immunology studies
Immunology studies
Find out moreFlow cytometry
Flow cytometry
Find out moreGPCR assays
GPCR assays
Find out moreExpression studies
Expression studies
Find out moreCell imaging
Cell imaging
Find out moreDiscovery toxicology
Discovery toxicology
Find out moreOur mission is to support clients to accelerate their drug discovery programmes from hypothesis to candidate selection.
Bespoke services include:
- Assay development and screening
- Immune cell assays
- Whole blood assays
- Functional assays
- Expression studies
- Flow cytometry assays
- Cell imaging
- Co-culture assays
- GPCR assays
- Discovery toxicology studies
Our team has considerable In vitro drug discovery experience in the following therapeutic areas:
- Immunology
- Oncology
- Immuno-oncology
- Inflammation
The story behind our name:
BioMedha comes from Bio (Greek for biology) and Medha (sanskrit for knowledge and rationale). Our scientists combine their expertise and knowledge in discovery biology to provide greater understanding in drug discovery.